Company Filing History:
Years Active: 2014
Title: Innovations of Ryan Link-Cole in Nucleotide Labeling
Introduction
Ryan Link-Cole is an accomplished inventor based in Monmouth, OR (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleotide labeling. His innovative approach has the potential to enhance various applications in genetic research and diagnostics.
Latest Patents
Ryan Link-Cole holds a patent for "Reagents and methods for direct labeling of nucleotides." This invention provides systems and methods for the production of activatable diazo-derivatives for use in labeling nucleotides. The process involves contacting a stable hydrazide derivative of a detectable moiety with an activating polymer reagent, allowing for direct labeling of the nucleotide sample. This method ensures that labeling occurs on the phosphate backbone of the nucleotide, which does not interfere with the hybridization of the labeled nucleotide with its anti-sense strand. Importantly, this direct labeling method allows for the labeling of all types of nucleotides without prior amplification or alteration. Ryan Link-Cole's patent represents a significant advancement in the field.
Career Highlights
Ryan Link-Cole is associated with Marker Gene Technology, Inc., where he continues to develop innovative solutions in biotechnology. His work focuses on improving methods for nucleotide labeling, which is crucial for various research applications. His expertise and dedication to advancing technology in this field have made him a valuable asset to his company.
Collaborations
Ryan collaborates with talented individuals such as John Joseph Naleway and Ying Jiang. These partnerships enhance the innovative efforts at Marker Gene Technology, Inc. and contribute to the development of cutting-edge technologies.
Conclusion
Ryan Link-Cole's contributions to nucleotide labeling through his patented methods exemplify the impact of innovation in biotechnology. His work not only advances scientific research but also opens new avenues for applications in genetics and diagnostics.